2 unknown, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Recruiting 1 |
Follow Initiator Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia) Pudafensine - Vulvodynia | Phase 2 | Recruiting | Initiator Pharma | 24 | 2025-12-17 | 2026-02-05 |
| A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction IPED2015, Placebo - Erectile Dysfunction | Phase 2 | Unknown | Initiator Pharma | 120 | 2021-08-04 | 2021-07-21 |
| Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients IP2018, Placebo - Erectile Dysfunction | Phase 2 | Unknown | Initiator Pharma | 24 | 2020-12-30 | 2023-03-01 |
Erectile Dysfunction (2) · Vulvodynia (1)
United Kingdom (2)
Abimbola Babajide, Dr (1) · Giuseppe Fiore Fiore, MD (1) · Paul Westhead, MD (1)